Why can't prescription drugs be swiped by medical insurance card?

Legal analysis: Under normal circumstances, the insurance expenses in the medical insurance card are shared by the individual and the company, with the company bearing 8% and the individual bearing 2%. Among them, 2% individuals enter the medical insurance card, which means that the insured can get a personal account, which can be used to buy medicines at designated pharmacies and pay for outpatient and hospitalization expenses. Most of the 8% paid by the company will enter the social pooling account and be managed by the medical insurance center. The expenses that the insured meet the local medical insurance reimbursement shall be paid by the overall account. According to the regulations, not all drugs can be paid with the money in the medical insurance card, and the medical insurance card can only buy drugs designated by medical insurance. The Social Security Bureau published a book —— Catalogue of Medicare Drugs, which published more than 1000 kinds of drugs, including amoxicillin, antiviral granules and commonly used cardiovascular and cerebrovascular drugs. According to this book, hospitals and pharmacies designated by social security can classify drugs that can be swiped and drugs that cannot be swiped.

Legal basis: In order to implement the key task of deepening the reform of medical and health system deployed by the CPC Central Committee and the State Council, the relevant departments have adjusted and improved the National Essential Drugs List (version 20 12) in accordance with the Measures for the Administration of National Essential Drugs List (Guo [2015] No.52) and other relevant regulations, and formed a ..

Please local health administrative departments at all levels (including departments in charge of traditional Chinese medicine) take the lead in implementing the Catalogue of National Essential Drugs (version 20 18) in strict accordance with the relevant requirements of the Opinions of the General Office of the State Council on Improving the National Essential Drugs System (Guo Ban Fa [2065] No.438), and timely summarize and report the problems encountered in the implementation process to the Office of the National Essential Drugs Working Committee (National Health